Navigation Links
Providence Service Corporation Issues Letter to Stockholders
Date:5/28/2009

vices of periodic reports with the SEC and the increasing commitment of its management's time to regulatory requirements, Avalon Correctional Services was considering terminating the registration of its shares of common stock under the Exchange Act as a way to cease being required to comply with these regulatory requirements.
  • On January 24, 2005, Avalon Correctional Services received a letter from Ravenswood Investment Company, which then held 7.2% of the outstanding shares of Avalon Correctional Services, expressing its concern with the announcement by Avalon Correctional Services that it was evaluating whether to remain a reporting company and with the absence of any independent directors on the Board of Directors of Avalon Correctional Services. In its letter, Ravenswood reminds Avalon Correctional Services that good corporate governance requires a majority of outside directors. Ravenswood also indicates that it is writing because Mr. Smith refused to return its telephone calls.
  • On February 3, 2005, with little advance notice to stockholders, and notwithstanding the potential adverse effects on the market for, and the liquidity of, the common stock of Avalon Correctional Services, Avalon Correctional Services publicly disclosed in a Form 8-K that it was terminating the registration of its shares under the Exchange Act to cease being required to comply with the SEC's periodic reporting requirements and the Sarbanes-Oxley Act (which include numerous corporate governance provisions for the protection of stockholders). Avalon Correctional Services also disclosed that its shares would no longer be listed on Nasdaq. Avalon Correctional Services indicated in its public filings that the financial impact of complying with the Sarbanes-Oxley Act could jeopardize its ability to continue as a going concern. As a result of this decision, Avalon Correctional Services now continues as a publicly-traded company that trades only on the "pink she
    '/>"/>

  • SOURCE The Providence Service Corporation
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine news :

    1. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
    2. Providence Service Corporation Announces 35% Revenue Growth with Third Quarter Results; Increases Revenue Guidance for 2007
    3. Providence Service Corporation Completes Private Placement of $70 Million of Convertible Senior Subordinated Notes
    4. Providence Service Corporation Signs Definitive Agreement to Acquire LogistiCare, the Nations Leading Case Management Provider Coordinating Non-Emergency Transportation Services for the Medicaid Population
    5. LogistiCare, a Subsidiary of Providence Service Corp., Opens Phoenix Call Center to Support Expanding Commercial Client Base
    6. Providence Service Corporation to Present at the 2008 UBS Global Healthcare Services Conference on February 11
    7. Providence Health & Services - Oregon Region Powers Consumer Portal With Kryptiq Connect IQ
    8. Providence Service Corporation to Report Fourth Quarter 2007 Results on Wednesday, March 12th After the Market Closes
    9. Providence Service Corporation and UnitedHealth Group Affiliate, OptumHealth Behavioral Solutions, Enter Into Strategic Relationship Agreement
    10. Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance
    11. Providence Service Corporation Announces Intent to File a Common Stock Shelf Registration Statement
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/25/2014)... Angeles, CA (PRWEB) July 25, 2014 In ... talk about, and eager to reverse the symptoms associated with ... in the media at large, a new case study ... real benefits of testosterone therapy using bioidentical hormones. ... a 38-year-old father from Seattle who found himself beginning to ...
    (Date:7/25/2014)... 2014 A federal judge has denied ... DePuy Pinnacle hip lawsuits ( http://www.depuypinnacle-lawsuit.com/ ) selected ... to go before a jury on September 1, 2014, ... July 18th, U.S. District Judge Ed Kinkeade of the ... claims may proceed to trial against Johnson & Johnson, ...
    (Date:7/25/2014)... (PRWEB) July 25, 2014 Ticket ... across the board for the Guinness International Champions Cup ... Olympiacos FC at Soldier Field on Sunday, July ... their customer appreciation promo/coupon/offer code SOCCER-2014 for added savings. ... year for diehard soccer fans in North America. Countless ...
    (Date:7/25/2014)... (GSA) the nation,s largest interdisciplinary organization devoted ... Heather M. Young, PhD, RN, FAAN, of the ... of the Doris Schwartz Gerontological Nursing Research Award. ... Sciences Section, is given to a member of ... contribution to gerontological nursing research. , The award ...
    (Date:7/25/2014)... Reproductive Science Center (RSC) of New ... Luzzo, Lead Physician at RSC Rhode Island, received the ... in fertility care and community outreach issued by Providence ... PBN Awards ceremony held July 24th at Salve Regina ... highly regarded, emerging leaders in their field were recognized ...
    Breaking Medicine News(10 mins):Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 2Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 4Health News:Liverpool FC vs. Olympiacos FC Tickets Soldier Field: Ticket Down Slashes Ticket Prices for Guinness International Champions Cup in Chicago on Sunday, July 27th 2Health News:Young earns GSA's 2014 Doris Schwartz Gerontological Nursing Research Award 2Health News:Dr. Kerri Luzzo of the Reproductive Science Center of Providence Receives “40 Under Forty Award" for Outstanding Professional Accomplishments and Community Outreach 2
    ... Imaging Ltd.,(the "Company") (Nasdaq: EMITF ), today announced ... the trustee for the holders of the,Series A, B ... the "Notes",respectively), that due to the signing of a ... Co., the controlling shareholder of,the Trustee, and Brightman, Almagor ...
    ... stopping infection , , TUESDAY, April 29 (HealthDay News) -- Most ... virus itself, but new research suggests that focusing on the ... because human cells mutate at much slower rates than does ... mutating around the drug, scientists explained. , The research is ...
    ... is available in German . , Leipzig. ... the Czech Republic and Poland did not so far lead ... Central Europe, there are other reasons for the presence of ... are the findings of a research project conducted by the ...
    ... Scientists at Johns Hopkins have outlined a new path ... and asthma based on a new understanding of the ... cavities. , Researchers say their findings, to be ... Allergy and Clinical Immunology, are the first evidence describing ...
    ... 29 Baptist Health System, one,of Alabama,s largest ... Group to bring together the health-improvement,needs of local ... at its four hospitals. Aegis brings nearly 20 ... services with the unique,healthcare needs of area employees., ...
    ... Success, NEW YORK, April 29 Flashpoint ... of the Omnicom Group,(NYSE: OMC ), was ... Medical,Advertising News at the publication,s annual Manny Awards ... by innovative thinking, powerful creative, and a,collaborative approach ...
    Cached Medicine News:Health News:Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes 2Health News:Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes 3Health News:Researchers Tackle HIV From a New Angle 2Health News:Researchers Tackle HIV From a New Angle 3Health News:Shrinkage and aging are Europe-wide challenges 2Health News:Shrinkage and aging are Europe-wide challenges 3Health News:Shrinkage and aging are Europe-wide challenges 4Health News:Immune system kick-started in moist nasal lining in sinusitis, asthma and colds 2Health News:Immune system kick-started in moist nasal lining in sinusitis, asthma and colds 3Health News:Alabama's Baptist Health System and Aegis Health Group Partner to Address Local Employers Health-Management Concerns 2Health News:Flashpoint Medica Named Agency of Year by Medical Advertising News 2
    (Date:7/24/2014)... -- Abaxis, Inc. (NasdaqGS: ABAX ), a medical ... financial results for the first fiscal quarter ended June ... Revenues of $47.5 million, up 10% over last year,s ... 50% over last year,s comparable quarter. Revenues ... up 20% over last year,s comparable quarter. , ...
    (Date:7/24/2014)... 24, 2014  IRIDEX Corporation (NASDAQ: IRIX ... quarter 2014 financial results after the market closes on ... the release, the Company will host a conference call ... Time on Thursday, July 31, 2014 ... business developments. Interested parties may access the ...
    (Date:7/24/2014)... , July 24, 2014 Omnicell, Inc. ... of medication and supply management solutions and analytics ... Thursday, July 31, to discuss the Company,s Second ... Second Quarter 2014 earnings conference call and webcastWhen: ... , Randall Lipps, chairman, president and chief executive ...
    Breaking Medicine Technology:Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2
    ... , June 28 Preliminary results of ... and hypertension demonstrated that the investigational triple combination therapy ... resulted in a statistically significant greater Least Squares (LS) ... 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P ...
    ... Tolerx, Inc., a biopharmaceutical company developing novel ... T cell activity, today announced the initiation of a ... in autoimmune new-onset type 1 diabetes. The confirmatory Phase ... For Early or New-Onset Type 1 Diabetes) and immediately ...
    Cached Medicine Technology:New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 2New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 3New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 4New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 5New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 6New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 7Tolerx Initiates Confirmatory Phase 3 Clinical Trial, DEFEND-2, with Otelixizumab for Type 1 Diabetes 2Tolerx Initiates Confirmatory Phase 3 Clinical Trial, DEFEND-2, with Otelixizumab for Type 1 Diabetes 3Tolerx Initiates Confirmatory Phase 3 Clinical Trial, DEFEND-2, with Otelixizumab for Type 1 Diabetes 4
    ... The Epi-K is a fully automated ... surgeons to,perform a new refractive procedure ... to,mechanically cleave the epithelium from the,Bowmans ... laser ablation.,Epi-Lasik preserves the structural integrity,of ...
    ... The Titan Procedure is a ... infrared light source to tighten skin ... The Titan heats the dermis to ... epidermis through continuous cooling. In addition, ...
    ... Confidence…real time , ... system for permanent, ... XLTEK ... IOM system. Both configurations feature ...
    ... Combining exceptional new ... design, XLTEKs latest innovation, ... delivers biphasic intracranial stimulation ... and 300 volts and ...
    Medicine Products: